Example of a worthy mission for a Biotech Project, The Merck-China hepatitis B Technology Transfer Project

In the early 1990’s Merck provided the recombinant hepatitis B technology to the People’s Republic of China. After the project and twenty years of vaccinating Chinese baby’s - hepatitis B was 90% eradicated. The health improvement was so remarkable that Merck assembled the original project team and the then Chairman of the Board, Dr. P. Roy Vagelos for a celebration in 2010. This is the story of how a worthy health mission can rally a project team to success, and the fulfillment of the health improvement.